Induction of cytotoxic T-cell activity by the protective antigen of Schistosoma mansoni Sm28GST or its derived C-terminal lipopeptide

Scandinavian Journal of Immunology

Volumn 44, Issue 5, 1996, Pages 485-492

  Pancre V ^a,b   Gras Masse, H ^a   Delanoye, A ^a   Herno, J ^a   Capron, A ^b   Auriault, C ^a  

^a INSTITUT PASTEUR   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GLUTATHIONE TRANSFERASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PARASITE ANTIGEN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; IMMUNIZATION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS;

EID: 0029829327     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1996.d01-340.x     Document Type: Article

References (31)

1. + T cells specific for a single nonamer epitope of Listeria monocytogenes are protective in vivo. J Exp Med 1992;175:1531-8.
2. Rotzschke O, Falk K, Deres K et al. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature 1990;348:252-4.
3. Romero P, Mariansky JL, Cordey AS, Corradin G, Nussenzweig RS, Zavala F. Isolation and characterization of protective cytolytic T cells in a rodent malaria model system. Immunol Lett 1990;25:27-31.
4. + cytotoxic T lymphocytes lyse Toxoplasma gondii-infected cells. J Immunol 1991;147:3955-9.
5. Yewdell JW, Bennick JR. Cell biology of antigen processing and presentation to MHC class I molecule-restricted T lymphocytes. Adv Immunol 1992;52:1-9.
6. Boros DL. Immunopathology of Schistosoma mansoni infection. Clin Microbiol Rev 1989;2:250-69.
7. Butterworth AE, Vadas MA, Martz E, Sher A. Cytolytic T lymphocytes recognize alloantigens on schistosomula of Schistosoma mansoni. but fail to induce damage. J Immunol 1986;122: 1314-21.
8. Mathew RC, Boros DL. Anti-L3T4 antibody treatment suppressed hepatic granuloma formation and abrogates antigen-induced interleukin-2 production in Schistosoma mansoni infection. Infect Immun 1986;54:820-6.
9. Mathew RC, Ragheb S, Boros DL. Recombinant IL-2 therapy reverses diminished granulomatous responsiveness in anti-L3T4-treated, Schistosoma mansoni - infected mice. J Immunol 1990; 144:4356-61.
10. + T lymphocytes in the suppression of granuloma formation and lymphokine production in Schistosoma mansoni-infected mice. J Immunol 1981;127:3630-5.
11. Fidel PL, Boros DL. Regulation of granulomatous inflammation in murine schistosomiasis. IV. Antigen-induced suppressor T cells down-regulate proliferation and IL-2 production. J Immunol 1990;145:1257-64.
12. Perrin PJ, Phillips SM. The molecular basis of granuloma formation in schistosomiasis. I. A T cell-derived suppressor effector factor. J Immunol 1988;141:1714-19.
13. Balloul JM, Grzych JM, Pierce RJ , Capron A. A purified 28,000 dalton protein from Schistosoma mansoni adult worms protects rats and mice against experimental schistosomiasis. J Immunol 1987;138:3448-53.
14. Wolowczuk I, Auriault C, Gras-Masse H et al. Protective immunity in mice vaccinated with the Schistosoma mansoni P-28 1 antigen. J Immunol 1989;142:1342-50.
15. Boulanger D, Reid GDF, Sturrock RF et al. Immunization of mice and baboons with the recombinant Sm28GST affects both worm viability and fecundity after experimental infection with Schistosoma mansoni. Parasite Immunol 1991;13:473-90.
16. Pancré V, Wolowczuk I, Guerret S et al. Protective effect of rSm28GST-specific T cells in Schistosomiasis : role of gamma interferon. Inf Immun 1994;62:3723-30.
17. + T cell clones secrete the ThI pattern of cytokines. J Immunol 1990; 144:1744-52.
18. + cytotoxic T-cell and Th1 cytokine responses as well us delayed virus clearance. Proc Natl Acad Sci USA 1993; 90:948-52.
19. + cytotoxic T-cell responses? A paradox revisited, Immunol Today 1993;14:344-8.
20. Pancré V, Wolowczuk I. Bossus M et al. Evaluation of the effect of Sm28GST-derived peptides in murine hepatosplenic schistosomiasis : interest of the lipopeptidic form of the C-terminal peptide. Molec Immunol 1994;31:1247-55.
21. Courtney M, Buchwalder A, Tessier LH et al. High level production of biologically active human-antitrypsin in Escherichia coli. Proc Natl Acad Sci USA 1994;81:669-74.
22. Merrifield RB. Solid phase peptide synthesis. J Am Chem Soc 1983;85:2149-54.
23. Balloul JM, Sondermeyer P, Dreyer D et al. Molecular cloning of a protective antigen of schistosomes. Nature 1987;326:149-53.
24. Khan IA , Smith KA, Kasper LH. Induction of antigen-specific parasiticidal cytotoxic T cell splenocytes by a major membrane protein (P30) of Toxoplasma gondii. J Immunol 1988;141:3600-5.
25. Wraith DC, Askonas BA. Induction of Influenza A virus crossreactive cytotoxic T cells by a Nucleoprotein/Haemagglutinin preparation. J Gen Virol 1985;66:1327- 3 1.
26. Tevethia S. Flyer DC, Tjian RJ. Biology of simian virus (SV40) transplantation antigen (TrAg). VI. Mechanism of induction of SV40 transplantation immunity in mice by purified SV40 T antigen (D2 Protein). Virology 1980;107:13-23.
27. Staerz UD, Karasuyama H, Garner AM. Cytotoxic T lymphocytes against a soluble protein. Nature 1987;329:449-51.
28. Ragheb S, Boros DL. Characterization of granuloma T lymphocyte function from Schistosoma mansoni- infected mice. J Immunol 1989;142:3239-46.
29. Schild H, Deres K, Wiesmüller KH, Jung G, Rammensee HG. Efficiency of peptides and lipopetides for in vivo priming of virus-specific cytotoxic T cells. Eur J Immunol 1991;21:2649-54.
30. Martinon F, Gras-Masse H, Boutillon Ch et al. Immunization of mice with lipopeptides bypasses the prerequisite for adjuvant. Immune response in BALB/c mice to human immunodeficiency virus envelope glycoprotein. J Immunol 1992;149:3416-22.
31. Rock K L. A new foreign policy: MHC class I molecules monitor the outside world. Immunol Today 1996;17:131-7.